Honduras First in Latin America to Offer Lenacapavir HIV Prevention
Published on Honduras Daily · Nov 5, 2026 · Originally reported November 4, 2026 by Radio Cadena Voces (RCV)
Honduras will become the first Latin American country to add lenacapavir — a twice-yearly injectable HIV preventive made by Gilead Sciences — to its public health system, available through 13 sexual-health clinics next quarter.
“Read in English” opens Radio Cadena Voces (RCV) via Google Translate; “Leer en Español” opens the original. Honduras Daily curates and summarizes; the reporting is theirs.